Harbin Medical University Cancer Hospital

Heilongjiang 150081

0 studies enrolling now · 3 studies all time

What they study most

Locally Advanced or Unresectable Metastatic Breast Cancer, Non-small Cell Lung Cancer, Platinum-resistant Ovarian Cancer, Stage IV Breast Cancer

Studies at this site

• Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed